Skip to main content

and
  1. No Access

    Article

    A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up

    Fifty-eight consecutive children with high-risk malignancies were treated with CY, and targeted topotecan followed by autologous hematopoietic cell transplantation (AHCT) in a phase I/II Institutional Review B...

    K A Kasow, C F Stewart, R C Barfield, N L Wright, C Li in Bone Marrow Transplantation (2012)